Severe hemolytic anemia due to passenger lymphocytes after living-related bowel transplant

被引:36
作者
Panaro, F
DeChristopher, PJ
Rondelli, D
Testa, G
Sankary, H
Popescu, M
Benedetti, E
机构
[1] Univ Illinois, Div Transplantat, Dept Surg, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA
[3] Univ Illinois, Dept Med, Div Hematol, Chicago, IL 60612 USA
[4] Univ Illinois, Dept Pediat Med, Chicago, IL 60612 USA
关键词
hemolytic anemia; living donor; passenger lymphocyte syndrome; small bowel transplant;
D O I
10.1111/j.1399-0012.2004.00158.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Hemolytic anemia following solid organ transplant may be caused by 'passenger' lymphocytes producing antibodies against erythrocytes. This phenomenon has never been described after intestinal transplant. Materials and methods: We report a case of severe, immune-mediated hemolysis due to symptomatic passenger lymphocyte syndrome (PLS) in a 4-yr-old recipient of living donor small bowel transplant. The Coombs'-positive hemolysis was caused by anti-A,B antibodies derived from donor lymphocytes in an ABO-compatible donor-recipient pair (O into A). Results: This complication was successfully and efficiently treated by the novel combined use of group O RBC transfusion, plasmapheresis and rituximab (anti-CD20). Conclusions: A severe hemolytic anemia due to PLS can occur in bowel transplantation. This complication should be considered when performing ABO-incompatible bowel transplant with a blood group O donor and an A or B recipient. Treatment with plasmapheresis, blood group O transfusion and rituximab has proved successful in our case.
引用
收藏
页码:332 / 335
页数:4
相关论文
共 21 条
[1]
RED-CELL ALLOANTIBODY DEVELOPMENT ASSOCIATED WITH HEART AND LUNG TRANSPLANTATION [J].
CUMMINS, D ;
CONTRERAS, M ;
AMIN, S ;
HALIL, O ;
DOWHAM, B ;
YACOUB, MH .
TRANSPLANTATION, 1995, 59 (10) :1432-1435
[2]
Fabrega AJ, 1996, CLIN TRANSPLANT, V10, P166
[3]
GREGOIRE JR, 1993, J AM SOC NEPHROL, V44, P157
[4]
Donor anti-Jka causing hemolysis in a liver transplant recipient [J].
Hareuveni, M ;
Merchav, H ;
Austerlitz, N ;
Rahimi-Leveen, N ;
Ben-Tal, O .
TRANSFUSION, 2002, 42 (03) :363-367
[5]
HAZLEHURST GR, 1986, SCAND J HAEMATOL, V37, P1
[6]
HOWS J, 1986, BLOOD, V67, P177
[7]
Jacobs LB, 1996, ARCH PATHOL LAB MED, V120, P684
[8]
Hemolytic reaction due to graft-versus-host (GVH) antibody production after liver transplantation from living donors: Report of two cases [J].
Kunimasa, J ;
Yurugi, K ;
Ito, K ;
Yamaoka, Y ;
Uemoto, S ;
Tanaka, K ;
Yoshida, H ;
Maruya, E ;
Saji, H ;
Yokoyama, S .
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1998, 28 (08) :857-861
[9]
Alloimmune hemolysis after renal transplantation [J].
Li, FK ;
Chan, TM ;
Lai, KN .
AMERICAN JOURNAL OF NEPHROLOGY, 2000, 20 (06) :473-475
[10]
Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL) [J].
Mounier, N ;
Briere, J ;
Gisselbrecht, C ;
Emile, JF ;
Lederlin, P ;
Sebban, C ;
Berger, F ;
Bosly, A ;
Morel, P ;
Tilly, H ;
Bouabdallah, R ;
Reyes, F ;
Gaulard, P ;
Coiffier, B .
BLOOD, 2003, 101 (11) :4279-4284